Showcasing Our Research at the EIAS Autumn Conference
Members of the Molecular Pathology Lab at the University of Tartu were invited to present their research at this year’s Estonian Society of Immunology and Allergology (EIAS) Autumn Conference. Held at the scenic Ugala Theater in Viljandi, the event brought together professionals from the scientific and medical fields, allowing for discussions about the latest advancements in immunology that are happening in Estonia.
Research Presentations by Our Team
Our lab contributed to the event with five presentations, each highlighting a unique area of research:
Sandra Meisalu: “Clinical and Immunological Characterization of Systemic Lupus Erythematosus Endotypes”
Sandra’s presentation shed light on the clinical and immune-related markers characteristic of three lupus endotypes, highlighting the need for personalized treatment approaches.
Martti Vanker: “Autoantibodies Against Cytokines in the Population”
Martti’s talk focused on the prevalence of certain cytokine-targeting autoantibodies, looking into their association with other factors such as age and sex and gene data.
Elise Helena Armulik: “The Effects of Inflammatory Pathways on the Development of Thymocytes”
Elise explored how inflammation pathways affect thymocyte development in mice embryos, offering insights into immune system regulation and potential therapeutic targets.
Tuuliki Pomerants: “The Challenges and Opportunities of Spectral Flow Cytometry”
Tuuliki discussed the benefits and complexities of spectral flow cytometry, in developing a panel that allows to immunophenotype various human cells
Gerli Rukis: “Exploring Resistance to COVID-19”
Gerli’s presentation highlighted key findings on resistance to COVID-19, contributing to the global understanding of immune responses to the virus.
We extend our heartfelt thanks to the organizers and fellow presenters for making the EIAS Autumn Conference a success. Events like these have an important role of bridging the gap and allowing for collaboration between the scientific community with the medical community as well.
As we continue advancing our work, including through the SysAge project, we look forward to future opportunities where we can contribute our research to the understanding of immunology and ageing.
